Ionis Pharmaceuticals (IONS) Short Interest
Nasdaq • IONS • US4622221004
As of Oct 22, 2026, ORTEX estimated 13.4% of free float sold short, 7.3 days to cover, cost to borrow 0.36%. Sign up for live short interest data.
Nasdaq • IONS • US4622221004
As of Oct 22, 2026, ORTEX estimated 13.4% of free float sold short, 7.3 days to cover, cost to borrow 0.36%. Sign up for live short interest data.
This page tracks how heavily Ionis Pharmaceuticals (Nasdaq:IONS) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Ionis Pharmaceuticals (Nasdaq: IONS) has a market capitalization of $6.55B. Last close $39.42 (as of 2026-11-09); 52-week range $38.31 to $86.74. ORTEX data as of 2026-10-22: short interest was 13.42% of free float, 7.3 days to cover and the average cost to borrow was 0.36%. Sign up for live short interest data.